{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:49:31Z","timestamp":1793191771745,"version":"4.5.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jtha.2022.12.023","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:38:36Z","timestamp":1673829516000},"page":"480-487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["The effect of a next generation factor VIII mimetic bispecific antibody (Mim8) on assays of factor VIII activity and thrombin generation"],"prefix":"10.1016","volume":"21","author":[{"given":"Annette Elizabeth","family":"Bowyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Kitchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirella","family":"Ezban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2022.12.023_bib1","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood.2020010331","article-title":"A\u00a0factor VIIIa-mimetic bispecific antibody, Mim8, ameliorates bleeding upon severe vascular challenge in hemophilia A mice","volume":"138","author":"\u00d8stergaard","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.12.023_bib2","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/hae.13990","article-title":"Effects of emicizumab on APTT, one-stage and chromogenic assays of factor VIII in artificially spiked plasma and in samples from haemophilia A patients with inhibitors","volume":"26","author":"Bowyer","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2022.12.023_bib3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/hae.13903","article-title":"Laboratory coagulation tests and emicizumab treatment A United Kingdom Haemophilia Centre Doctors' Organisation guideline","volume":"26","author":"Jenkins","year":"2020","journal-title":"Haemophilia"},{"issue":"Suppl 6","key":"10.1016\/j.jtha.2022.12.023_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"WFH Guidelines for the Management of Hemophilia panelists and co-authors. WFH Guidelines for the Management of Hemophilia, 3rd edition","volume":"26","author":"Srivastava","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2022.12.023_bib5","unstructured":"Bowyer AE, Kitchen S, Ezban M. Assessment of a new chromogenic FVIII assay in severe haemophilia A plasma containing emicizumab (abstract), in THSNA. 2020: virtual."},{"issue":"Suppl 1","key":"10.1016\/j.jtha.2022.12.023_bib6","first-page":"26","article-title":"A\u00a0novel chromogenic method for measuring factor VIII activity in the presence of the bispecific antibody emicizumab","volume":"28","author":"Schrenk","year":"2022","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2022.12.023_bib7","first-page":"43","article-title":"Preclinical characterisation of MIM8-A next-generation FVIII mimetic bispecific antibody","volume":"26","author":"Kjellev","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2022.12.023_bib8","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/ijlh.12342","article-title":"Effects of storage and thawing conditions on coagulation testing","volume":"37","author":"Gosselin","year":"2015","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtha.2022.12.023_bib9","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.3324\/haematol.2013.088088","article-title":"Specific and global coagulation assays in the diagnosis of discrepant mild hemophilia A","volume":"98","author":"Bowyer","year":"2013","journal-title":"Haematologica"},{"issue":"S1","key":"10.1016\/j.jtha.2022.12.023_bib10","first-page":"101","article-title":"FRONTIER1: A Phase 1\/2 Dose Escalation Study of a Novel Factor VIIIa Mimetic Bispecific Antibody, Mim8, for Evaluation of Safety, Pharmacokinetics, and Efficacy [abstract]","volume":"6","author":"Chowdary","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.12.023_bib11","first-page":"4","article-title":"Effect of emicizumab (ACE910)-a humanized bispecific antibody mimicking FVIIIa cofactor function-on coagulation assays commonly in use for monitoring of hemophilia a patients","volume":"23","author":"Adamkewicz","year":"2017","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2022.12.023_bib12","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1182\/blood-2019-128159","article-title":"Next-generation FVIII mimetic shows superior effect in a FIX-and Fx-humanized mouse model in\u00a0vivo","volume":"134","author":"Ley","year":"2019","journal-title":"Blood"},{"issue":"Suppl 2","key":"10.1016\/j.jtha.2022.12.023_bib13","first-page":"P028","article-title":"Improved effect of Mim8, a next-generation FVIII mimetic, translates from human in\u00a0vitro to humanized mouse and cynomolgus models","volume":"26","author":"Ley","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2022.12.023_bib14","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1160\/TH17-01-0030","article-title":"Factor VIIIa-mimetic cofactor activity of a bispecific antibody to factors IX\/IXa and X\/Xa, emicizumab, depends on its ability to bridge the antigens","volume":"117","author":"Kitazawa","year":"2017","journal-title":"Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622190732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622190732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:37:40Z","timestamp":1761536260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622190732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1538783622190732"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2022.12.023","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of a next generation factor VIII mimetic bispecific antibody (Mim8) on assays of factor VIII activity and thrombin generation","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2022.12.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2023 Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}